Treatment of disorders of adult bronchial secretion, especially in acute bronchial and acute episodes of chronic bronchopneumopathies

RESERVED FOR THE ADULT.

5 ml of oral solution contains 30 mg of ambroxol hydrochloride.

The mean dosage of ambroxol hydrochloride is 60 to 120 mg per day divided into 2 divided 5 to 10 ml twice daily (morning and evening).

A 2.5 mL, 5 mL, 7.5 mL, 10 mL, 15 mL or 5 mL measuring spoon is provided to measure the amount of active ingredient for an intake of < Code>

Either 5 ml to 10 ml of the measuring cup or 1 to 2 measuring spoons

Pharmacotherapeutic group, MUCOLYTICS, ATC code: R05CB06.

Ambroxol has mucokinetic and expectorant properties.

It stimulates, by its action on the secretory cells, the secretion, bronchial and promotes the production of a more mobilizable mucus.It increases the ciliary activity.
Not applicable.

History of hypersensitivity reactions to any of the constituents

The association of a bronchial mucomodifier with an antitussive and / or substances, which dry out the (atropinic) secretions is irrational.
This medicinal product contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) and may cause allergic reactions (possibly delayed). >
This medicinal product contains sorbitol and is not recommended for use in patients with fructose intolerance

Due to the presence of sorbitol, this medication may cause a laxative, moderate effect.

Not applicable.

Not applicable.

In case of overdose, the treatment will be symptomatic.

Pregnancy

Studies in animals have not shown any teratogenic effect. In the absence of a teratogenic effect in animals, a malformative effect in the human species is not expected.

Indeed, to date, substances responsible for malformations in the human species have been shown to be teratogenic in animals in well-conducted studies of two species
< Br>

In clinical studies, there is currently no adequate data to evaluate a possible malformative or fetotoxic effect of the hydrochloride of ambroxol when administered during pregnancy. >

Therefore, as a precautionary measure, it is preferable not to use ambroxol hydrochloride during pregnancy.


In case of breast-feeding, the use of this product is not recommended.
Minor gastrointestinal effects such as nausea, vomiting, gastralgia, pyrosis, dyspepsia have been reported rarely.


O Cases of mucocutaneous reactions to type, erythema, rash, pruritus, urticaria

O very rarely anaphylactoid manifestations with shock occurrence and edema of Quincke which have been favorable in the reported cases.


ยท Cases of headache and vertigo were also very rarely described

Treatment of disorders of adult bronchial secretion, especially in acute bronchial and acute episodes of chronic bronchopneumopathies